Guan YS, He Q, Wang MQ, Li P. Nuclear factor kappa B and hepatitis viruses.
Expert Opin Ther Targets 2008;
12:265-80. [PMID:
18269337 DOI:
10.1517/14728222.12.3.265]
[Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
BACKGROUND
Hepatitis can be caused by a number of viruses, which have similar clinical manifestations and render infected individuals at high risk of death from cirrhosis and liver cancer. Current therapies for hepatitis have limited effects and unsatisfactory patient outcomes. Nuclear factor kappa B (NF-kappaB) is critical for immune and inflammatory responses. During its lifetime the cell demands specific and highly regulated control of NF-kappaB activity.
OBJECTIVE
To develop novel strategies to overcome various hepatitides and related liver cancer with NF-kappaB as the key point.
METHODS
All aspects of NF-kappaB control with regard to hepatitis are covered.
RESULTS/CONCLUSION
NF-kappaB plays an important role in the process of hepatitis and is hypothesized to be an anti-cancer factor in the subsequent inflammation-associated hepatocarcinogenesis.
Collapse